Jagsonpal Pharmaceuticals Completes Acquisition of Majority Stake in Aequitas Healthcare, Establishes Subsidiary Status
Jagsonpal Pharmaceuticals Ltd has successfully completed the acquisition of a significant equity stake in Aequitas Healthcare Private Limited ("Aequitas"). Following the transaction, Aequitas is now established as a subsidiary of Jagsonpal Pharmaceuticals Limited.The company reported that it had initially planned to acquire an 85% stake in Aequitas. However, the completed transaction involved the acquisition of 69.77% of the equity in Aequitas.
This strategic acquisition marks a key operational development for Jagsonpal Pharmaceuticals as it formalizes control over Aequitas Healthcare through this majority stake.
JAGSNPHARM Stock Price Movement
Jagsonpal Pharmaceuticals Limited is shedding value as of 1:47 PM, with shares currently trading at ₹235 after slipping by 0.81%.The stock saw a substantial daily trading volume, moving through 98,998 shares during the live market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.